![Amy Trevvett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Amy Trevvett is currently the Head of Media Relations at Dicerna Pharmaceuticals, Inc. She previously worked as the Director of Corporate Communications at Sumitomo Pharma America, Inc. and as the VP of Corporate Communications and Investor Relations at Alaunos Therapeutics, Inc.
Posizioni attive di Amy Trevvett
| Società | Posizione | Inizio |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Public Communications Contact | - |
Precedenti posizioni note di Amy Trevvett
| Società | Posizione | Fine |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Public Communications Contact | - |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Contatto Relazioni con gli Investitori | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
5
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
